Joseph K - Search Results

1

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy.

Chan AM, Roldan Urgoiti G, Jiang W, Lee S, Kornaga E, Mathen P, Yeung R, Enwere EK, Box A, Konno M, Koebel M, Joseph K, Doll CM. Chan AM, et al. Among authors: joseph k. Front Oncol. 2022 Oct 7;12:1000263. doi: 10.3389/fonc.2022.1000263. eCollection 2022. Front Oncol. 2022. PMID: 36276142 Free PMC article.

2

The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.

Banerjee R, Roxin G, Eliasziw M, Joseph K, Maclean A, Buie WD, Doll C. Banerjee R, et al. Among authors: joseph k. Dis Colon Rectum. 2013 Sep;56(9):1036-42. doi: 10.1097/DCR.0b013e31829ab0d4. Dis Colon Rectum. 2013. PMID: 23929012

3

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.

Yeung R, McConnell Y, Roxin G, Banerjee R, Urgoiti GB, MacLean AR, Buie WD, Mulder KE, Vickers MM, Joseph KJ, Doll CM. Yeung R, et al. Among authors: joseph kj. Curr Oncol. 2014 Jun;21(3):e449-56. doi: 10.3747/co.21.1903. Curr Oncol. 2014. PMID: 24940105 Free PMC article.

4

Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.

Yeung R, McConnell Y, Warkentin H, Graham D, Warkentin B, Joseph K, Doll CM. Yeung R, et al. Among authors: joseph k. Radiat Oncol. 2015 Apr 17;10:92. doi: 10.1186/s13014-015-0398-4. Radiat Oncol. 2015. PMID: 25903798 Free PMC article.

5

Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.

Joseph K, Nijjar Y, Warkentin H, Schiller D, Tankel K, Usmani N, Severin D, Ghosh S, Syme A, Nijjar T, Mulder K, Doll C, Wong C, Field C. Joseph K, et al. Radiother Oncol. 2015 Nov;117(2):234-9. doi: 10.1016/j.radonc.2015.08.008. Epub 2015 Aug 22. Radiother Oncol. 2015. PMID: 26306677 Clinical Trial.

6

Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.

Duimering A, Riauka T, Nijjar Y, Ghosh S, MacEwan R, Warkentin H, Schiller D, Tankel K, Usmani N, Severin D, Nijjar T, Fairchild A, Mulder K, Doll C, Wong C, Joseph K. Duimering A, et al. Among authors: joseph k. Radiother Oncol. 2019 Jul;136:21-28. doi: 10.1016/j.radonc.2019.03.014. Epub 2019 Apr 4. Radiother Oncol. 2019. PMID: 31015125

7

Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients.

Yang R, Younis M, Joseph K, Ghosh S, Nijjar T, Severin D, Tankel K, Tamhane Y, Fairchild A, Spratlin J, Mulder K, Usmani N. Yang R, et al. Among authors: joseph k. J Oncol Pharm Pract. 2021 Oct;27(7):1596-1603. doi: 10.1177/1078155220962192. Epub 2020 Oct 6. J Oncol Pharm Pract. 2021. PMID: 33023385

8

Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.

Joseph K, Balushi MA, Ghosh S, Stenson T, Abraham A, Elangovan A, Warkentin H, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Doll C, King K, Nijjar T. Joseph K, et al. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):434-445. doi: 10.1016/j.ijrobp.2023.04.023. Epub 2023 May 4. Int J Radiat Oncol Biol Phys. 2023. PMID: 37148982 Clinical Trial.

9

A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.

Joseph K, Al Habsi Z, Abraham A, Elangovan A, Ghosh S, Pham T, Shreekumar D, Ramji Z, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Karachiwala H, Doll C, King K, Nijjar T. Joseph K, et al. Radiother Oncol. 2024 Mar 12;196:110219. doi: 10.1016/j.radonc.2024.110219. Online ahead of print. Radiother Oncol. 2024. PMID: 38479443

10

Prognostic significance of number of positive nodes: a long-term study of one to two nodes versus three nodes in breast cancer patients.

Tai P, Yu E, Joseph K. Tai P, et al. Among authors: joseph k. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):180-7. doi: 10.1016/j.ijrobp.2009.04.073. Int J Radiat Oncol Biol Phys. 2010. PMID: 20394852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,131 results

Search Page